HYBRID EVENT: You can participate in person at Singapore or Virtually from your home or work.

7th Edition of

International Nutrition Research Conference

March 27-29, 2025 | Singapore

Nutri 2025

Supremacy of micronutrients and nutraceuticals on thinking function and performance in alzheimer’s disease

Speaker at International Nutrition Research Conference 2025 - Mihir Y Parmar
Dr's Kiran & Pallavi Patel Global University, India
Title : Supremacy of micronutrients and nutraceuticals on thinking function and performance in alzheimer’s disease

Abstract:

Alzheimer’s disease (AD) is a major world health issue today and is the much more common form of dementia (Memory loss). AD is characterized by the formation of β-amyloid (Aβ) plaques & neurofibrillary clusters, leading to decline in brain acetylcholine levels of the brain. Another contrivance underlying the pathogenesis of AD is the abnormal phosphorylation of tau protein that accumulates at the level of neurofibrillary aggregates, and the areas most affected by this pathological process are usually the cholinergic neurons in cortical, subcortical & hippocampal areas. These effects result in decreased cognitive function, brain atrophy, and neuronal death. Malnutrition and weight loss are the most frequent manifestations of AD, and these are also associated with greater cognitive decline. Several studies have confirmed that a balanced low-calorie diet and proper nutritional intake may be considered important factors in counteracting or slowing the progression of AD, whereas a high-fat or hypercholesterolemic diet predisposes to an increased risk of developing AD. Especially, fruits, vegetables, antioxidants, vitamins, polyunsaturated fatty acids, and micronutrients supplementation exert positive effects on aging-related changes in the brain due to their antioxidant, anti-inflammatory, and radical scavenging properties. The object of this review is to summarize some possible nutritional factors that may contribute to the progression or prevention of AD, understand the role that nutrition plays in the formation of Aβ plaques typical of this neurodegenerative disease, to identify some potential therapeutic strategies that may involve some natural compounds, in delaying the progression of the disease.

Biography:

Dr. Mihir Y. Parmar is Approved Professor of Pharmacology with over 16 years of Pharmaceutical Experience in Research & Academy. Dr. Parmar research interests include evaluation of Drug induced liver injury, Diabetes Mellitus, & its Microvascular Complications, Nephrotoxicity, Behavioural Pharmacology, Complementary and Alternative Medicines, IBD, Alzheimer’s, Parkinson Disease, Toxicology and many more. Dr. Parmar has over 85 national & international publications in impact factor journal. Currently He is performing reviewer duty for Human and Experimental Toxicology Journal and Research Journal of Food Science & Nutrition, Pharmaceutical Nanotechnology, Current Drug Delivery & more. Member of Editorial team for Asian Journal of Pharmaceutical Research & Development and J of Emerging Technology Innovation & Research, J of Diabetes & Endocrinology more.

Watsapp